Business expansion
Location of affected unit(s)
Cork, Dublin and Kildare
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

300 jobs
Number of planned job creations
Job creation
Announcement Date
2 November 2020
Employment effect (start)
Foreseen end date
30 November 2023


Pfizer is to create 300 jobs at three Irish sites - Grange Castle in West Dublin, Ringaskiddy (Co. Cork) and Newbridge (Co. Kildare) -  over the next 2 - 3 years. The company announced an investment of €300m in its Irish operations to support the further development of the three sites. The new roles are highly skilled positions including analysts, technicians, engineers, scientists, technologists, quality specialists, data analysts and chemists.

Pfizer has been operating in Ireland since 1969 and has 4,000 workers across in six locations.

"This is a very important development as it expands Pfizer's role in Ireland from the manufacture of already approved medicines into supporting the earlier phases of new medicine development," the company said. Martin Shanahan, the CEO of IDA Ireland, said today's investment announcement and the substantial number of additional highly skilled roles across its three Irish sites is a huge vote of confidence in Ireland's investment environment.

Mr Shanahan said it again underscores Ireland's reputation as a global location of excellence for biopharmaceuticals.



Eurofound (2020), Pfizer, Business expansion in Ireland, factsheet number 102593, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/102593.